(JAMA Neurology) About 170 multiple sclerosis (MS) patients at Charing Cross Hospital in London reported side effects, including relapses, after being switched from Tysabri brand of natalizumab to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback